BlackRock Inc. - ABVC BIOPHARMA INC ownership

ABVC BIOPHARMA INC's ticker is ABVC and the CUSIP is 00091F106. A total of 6 filers reported holding ABVC BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ABVC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$3,020
-88.9%
5,814
-86.4%
0.00%
Q1 2023$27,294
+6.0%
42,647
+3.5%
0.00%
Q4 2022$25,758
-24.2%
41,213
+6.6%
0.00%
Q3 2022$34,000
-17.1%
38,665
-1.0%
0.00%
Q2 2022$41,00039,0420.00%
Other shareholders
ABVC BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,092,745$1,158,0000.02%
VANGUARD GROUP INC 375,142$398,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 49,915$52,0000.00%
BlackRock Inc. 39,042$41,0000.00%
Tower Research Capital LLC (TRC) 5,997$6,0000.00%
View complete list of ABVC BIOPHARMA INC shareholders